5505 MOREHOUSE DRIVE, SUITE 300, SAN DIEGO, CA
News, Articles of Incorporation, Bylaws
Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio
Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Changes in Board, Management or Compensation
Announces Closing of Upsized $358 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Q3
Notice of Suspension of Duty to File Reports
Solicitation/Recommendation Statement
Tender Offer Statement by Third Party
Schedule 14D-9C Solicitation/Recommendation Statement Communication
Tender Offer Statement by Issuer
Registration Statement for Securities to be Offered to Employees
No filings found
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
S-8 POS
Amended Schedule 14D-9 Solicitation/Recommendation Statement
Amended Tender Offer Statement by Third Party
Correspondence
Submission Upload